The lawsuit was prompted by several recent HHS actions the plaintiffs noted were “designed to mislead, confuse, and gradually desensitize the public to anti-vaccine and anti-science rhetoric.” ...

Tividenofusp alfa is a novel central nervous system-penetrant enzyme replacement therapy designed to address the neurological manifestations of MPS II by delivering IDS into the brain and body.

The Food and Drug Administration (FDA) has approved Ekterly ® (sebetralstat) for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged 12 years and older.

After 8 months of taking the wrong medication, Miss G developed a rash. Her mother took her to the emergency department (ED) ...

Products containing synthetic dyes have 141 percent higher mean total sugar, lower levels of sodium, saturated fat.

Percentage increase in estimated mean annual HTN deaths from excessive alcohol use higher among women than men.

HealthDay News — There has been nationwide total of 1267 confirmed cases of measles this year, with Kentucky being the latest state to announce an outbreak, the US Centers for Disease Control and ...

National health care expenditure growth expected to outpace GDP, resulting in a health share of GDP that reaches 20.3% by 2033.

The wearable, transcutaneous neurostimulation device delivers personalized therapy using a proprietary AI algorithm.

The approval of sunvozertinib, an oral irreversible EGFR inhibitor, was supported by data from the WU-KONG1B trial (ClinicalTrials.gov Identifier: NCT03974022 ). The primary efficacy population ...

The Food and Drug Administration (FDA) has granted accelerated approval to Lynozyfic™ (linvoseltamab-gcpt) for the treatment of adult patients with ...

Wristband that provides relief for upper limb tremor is approved; FDA warns of clinically significant weight loss in younger kids taking ADHD meds; REMS removed for CAR T-cell immunotherapies; ...